Sophiris Bio Gets $10M Loan From Silicon Valley Bank

San Diego-based Sophiris Bio reported this morning that it has received $10M in two term loans from Silicon Valley Bank, to go towards manufacturing for its Phase 3 clinical trials. According to Sophiris Bio, it borrowed $7M of the amount on Tuesday. Sophiris is a biopharmaceuticals firm developing treatments for patients with urological disease. Sophiris is led by President and CEO Randall E. Woods.